心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 专家共识文件：法布里病心血管表现的管理

2020-07-08 国外心血管相关专家小组（统称） Eur J Heart Fail . 2020 Jul 8.

法布里病

法布里病是α-半乳糖苷酶A（α-GalA）的基因突变导致的X染色体遗传性多系统溶酶体贮积病。法布里病可影响多个系统，包括神经、肾脏、皮肤以及心脏也可局限于心脏。本文主要总结了法

中文标题：

2020 专家共识文件：法布里病心血管表现的管理

英文标题：

An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease

发布机构：

国外心血管相关专家小组（统称）

发布日期：

2020-07-08

简要介绍：

法布里病是α-半乳糖苷酶A（α-GalA）的基因突变导致的X染色体遗传性多系统溶酶体贮积病。法布里病可影响多个系统，包括神经、肾脏、皮肤以及心脏也可局限于心脏。本文主要总结了法布里病心血管表现的管理意见。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 专家共识文件：法布里病心血管表现的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=44dbe1c00193e784, title=2020 专家共识文件：法布里病心血管表现的管理, enTitle=An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease, guiderFrom=Eur J Heart Fail . 2020 Jul 8., authorId=0, author=, summary=法布里病是&alpha;-半乳糖苷酶A（&alpha;-GalA）的基因突变导致的X染色体遗传性多系统溶酶体贮积病。法布里病可影响多个系统，包括神经、肾脏、皮肤以及心脏也可局限于心脏。本文主要总结了法, cover=https://img.medsci.cn/2020717/1594969317577_2020535.jpg, journalId=0, articlesId=null, associationId=738, associationName=国外心血管相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jul 08 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>法布里病是&alpha;-半乳糖苷酶A（&alpha;-GalA）的基因突变导致的X染色体遗传性多系统溶酶体贮积病。法布里病可影响多个系统，包括神经、肾脏、皮肤以及心脏也可局限于心脏。本文主要总结了法布里病心血管表现的管理意见。</p> </div> </div> </div>, tagList=[TagDto(tagId=39408, tagName=法布里病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21072, categoryName=梅斯医学-罕见病网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=39408, guiderKeyword=法布里病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2683, appHits=101, showAppHits=0, pcHits=469, showPcHits=2582, likes=2, shares=3, comments=6, approvalStatus=1, publishedTime=Fri Jul 17 15:03:30 CST 2020, publishedTimeString=2020-07-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Jul 17 15:02:08 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 01:52:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 专家共识文件：法布里病心血管表现的管理.pdf)])
2020 专家共识文件：法布里病心血管表现的管理.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070660, encodeId=810710e0660ae, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 09:00:50 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896606, encodeId=c523896606a3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd582277740, createdName=121bb8d4m13暂无昵称, createdTime=Tue Nov 03 14:36:14 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882253, encodeId=f72b8822530a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Wed Sep 02 20:05:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2021-11-16 1e22b426m70(暂无匿称)

    值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070660, encodeId=810710e0660ae, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 09:00:50 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896606, encodeId=c523896606a3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd582277740, createdName=121bb8d4m13暂无昵称, createdTime=Tue Nov 03 14:36:14 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882253, encodeId=f72b8822530a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Wed Sep 02 20:05:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-11-03 121bb8d4m13暂无昵称

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070660, encodeId=810710e0660ae, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 09:00:50 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896606, encodeId=c523896606a3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd582277740, createdName=121bb8d4m13暂无昵称, createdTime=Tue Nov 03 14:36:14 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882253, encodeId=f72b8822530a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Wed Sep 02 20:05:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-02 逆行星

    谢谢

    0

相关指南

2016 法布里病疼痛的诊断和管理建议

国外神经内科相关专家小组（统称） · 2016-05-28

拓展阅读

2016 法布里病疼痛的诊断和管理建议

国外神经内科相关专家小组（统称） · 2016-05-28

2021 TSOC 法布里病心脏表现的临床特征、诊断和临床管理专家共识

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2021-07-16

2021 TSOC专家共识：法布里病心脏表现的临床特点、诊断和临床管理

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2021-07-10

法国专家共识：典型法布里病的临床实践建议和指南

French Referral Center for Fabry disease and MetabERN European Reference Network for Inherited Metabolic Diseases, Division of Medical Genetics, University of Versailles, Paris-Saclay University · 2022-08-01

2023 专家共识建议：生物标志物在法布里病中的应用

国外遗传代谢性疾病专家组（统称） · 2023-04-17

2023 NICE 技术鉴定指南：用于治疗法布里病的 Pegunigalsidase alfa[TA915]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-10-04